Nanae Aritaka

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

Keiichi Hiramatsu, Nanae Aritaka, Hideaki Hanaki et al. · The Lancet · 1997 · 1.3K citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +11

T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma

Yasushi Isobe, Nanae Aritaka, Yasuhiro Setoguchi et al. · Journal of Clinical Pathology · 2012 · 54 citations

Ebv Viral Load, Lymphoid Neoplasia, Epstein-barr Virus +14

Combination Effect of Vancomycin and β-Lactams against a <i>Staphylococcus</i> <i>aureus</i> Strain, Mu3, with Heterogeneous Resistance to Vancomycin

Nanae Aritaka, Hideaki Hanaki, Longzhu Cui et al. · Antimicrobial Agents and Chemotherapy · 2001 · 38 citations · Full text

“Slow VISA,” a Novel Phenotype of Vancomycin Resistance, Found <i>In Vitro</i> in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3

Michie Saito, Yuki Katayama, Tomomi Hishinuma et al. · Antimicrobial Agents and Chemotherapy · 2014 · 36 citations · Full text

Microbial Pathogens, Bacteriology, Antibiotic Resistance +21

Spontaneous regression of natural killer cell lymphoma

Yasushi Isobe, Nanae Aritaka, Makoto Sasaki et al. · Journal of Clinical Pathology · 2009 · 33 citations

Spontaneous Tumour Regression, Lymphoid Neoplasia, Autoimmune Disease +12